{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:18:56Z","timestamp":1707524336521},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,7,13]]},"DOI":"10.7759\/cureus.16354","type":"journal-article","created":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T11:55:55Z","timestamp":1626177355000},"source":"Crossref","is-referenced-by-count":0,"title":["Management of Chronic Symptoms of Lyme Disease With Intravenous Ceftriaxone"],"prefix":"10.7759","author":[{"given":"Muhammad","family":"Naeem","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek","family":"Enos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shazia","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nidhi","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tara","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.idc.2015.02.010","article-title":"Epidemiology of Lyme disease","volume":"29","author":"Mead PS","year":"2015","unstructured":"Mead PS. Epidemiology of Lyme disease. Infect Dis Clin North Am. 2015, 29:187-210. 10.1016\/j.idc.2015.02.010","journal-title":"Infect Dis Clin North Am"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.14745\/ccdr.v40i11a01","article-title":"Lyme disease: clinical diagnosis and treatment","volume":"40","author":"Hatchette TF","year":"2014","unstructured":"Hatchette TF, Davis I, Johnston BL. Lyme disease: clinical diagnosis and treatment. Can Commun Dis Rep. 2014, 40:194-208. 10.14745\/ccdr.v40i11a01","journal-title":"Can Commun Dis Rep"},{"key":"ref3","article-title":"Lyme Disease","author":"Skar GL","year":"2020","unstructured":"Skar GL, Simonsen KA. Lyme Disease. StatPearls Publishing, Treasure Island, FL; 2020."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01409-14","article-title":"Collection and characterization of samples for establishment of a serum repository for lyme disease diagnostic test development and evaluation","volume":"52","author":"Molins CR","year":"2014","unstructured":"Molins CR, Sexton C, Young JW, Ashton LV, Pappert R, Beard CB, Schriefer ME. Collection and characterization of samples for establishment of a serum repository for lyme disease diagnostic test development and evaluation. J Clin Microbiol. 2014, 52:3755-3762. 10.1128\/JCM.01409-14","journal-title":"J Clin Microbiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6832a4","article-title":"Updated CDC recommendation for serologic diagnosis of Lyme disease","volume":"68","author":"Mead P","year":"2019","unstructured":"Mead P, Petersen J, Hinckley A. Updated CDC recommendation for serologic diagnosis of Lyme disease. Morb Mortal Wkly Rep. 2019, 68:703. 10.15585\/mmwr.mm6832a4","journal-title":"Morb Mortal Wkly Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S23829","article-title":"Benefit of intravenous antibiotic therapy in patients referred for treatment of neurologic Lyme disease","volume":"4","author":"Stricker RB","year":"2011","unstructured":"Stricker RB, Delong AK, Green CL, Savely VR, Chamallas SN, Johnson L. Benefit of intravenous antibiotic therapy in patients referred for treatment of neurologic Lyme disease. Int J Gen Med. 2011, 4:639-646. 10.2147\/IJGM.S23829","journal-title":"Int J Gen Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1086\/521256","article-title":"Reinfection in patients with Lyme disease","volume":"45","author":"Nadelman RB","year":"2007","unstructured":"Nadelman RB, Wormser GP. Reinfection in patients with Lyme disease. Clin Infect Dis. 2007, 45:1032-1038. 10.1086\/521256","journal-title":"Clin Infect Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2014.09.004","article-title":"Lyme disease: a rigorous review of diagnostic criteria and treatment","volume":"57","author":"Borchers AT","year":"2015","unstructured":"Borchers AT, Keen CL, Huntley AC, Gershwin ME. Lyme disease: a rigorous review of diagnostic criteria and treatment. J Autoimmun. 2015, 57:82-115. 10.1016\/j.jaut.2014.09.004","journal-title":"J Autoimmun"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1172\/JCI138062","article-title":"Posttreatment Lyme disease syndromes: distinct pathogenesis caused by maladaptive host responses","volume":"130","author":"Steere AC","year":"2020","unstructured":"Steere AC. Posttreatment Lyme disease syndromes: distinct pathogenesis caused by maladaptive host responses. J Clin Invest. 2020, 130:2148-2151. 10.1172\/JCI138062","journal-title":"J Clin Invest"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-012-0126-6","article-title":"Post-treatment Lyme disease syndrome symptomatology and the impact on life functioning: is there something here?","volume":"22","author":"Aucott JN","year":"2013","unstructured":"Aucott JN, Rebman AW, Crowder LA, Kortte KB. Post-treatment Lyme disease syndrome symptomatology and the impact on life functioning: is there something here?. Qual Life Res. 2013, 22:75-84. 10.1007\/s11136-012-0126-6","journal-title":"Qual Life Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.cll.2015.08.004","article-title":"Clinical manifestations and treatment of Lyme disease","volume":"35","author":"Sanchez JL","year":"2015","unstructured":"Sanchez JL. Clinical manifestations and treatment of Lyme disease. Clin Lab Med. 2015, 35:765-778. 10.1016\/j.cll.2015.08.004","journal-title":"Clin Lab Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe1502350","article-title":"Time for a different approach to Lyme disease and long-term symptoms","volume":"374","author":"Melia MT","year":"2016","unstructured":"Melia MT, Auwaerter PG. Time for a different approach to Lyme disease and long-term symptoms. N Engl J Med. 2016, 374:1277-1278. 10.1056\/NEJMe1502350","journal-title":"N Engl J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/61552-management-of-chronic-symptoms-of-lyme-disease-with-intravenous-ceftriaxone","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:27:01Z","timestamp":1707506821000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/61552-management-of-chronic-symptoms-of-lyme-disease-with-intravenous-ceftriaxone"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,13]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.16354","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7,13]]}}}